Introduction of 1,3-Diethyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-ylidene as New Ligand for the Design of Antitumor-Active (NHC)gold(I) Complexes: An Approach to Reduce Ligand Scrambling and to Increase Tumor Cell Selectivity

IF 6 2区 医学 Q1 CHEMISTRY, MEDICINAL
Amelie Scherfler, Stefan Schwaiger, Klaus Wurst, Brigitte Kircher, Daniel Baecker, Ronald Gust
{"title":"Introduction of 1,3-Diethyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-ylidene as New Ligand for the Design of Antitumor-Active (NHC)gold(I) Complexes: An Approach to Reduce Ligand Scrambling and to Increase Tumor Cell Selectivity","authors":"Amelie Scherfler, Stefan Schwaiger, Klaus Wurst, Brigitte Kircher, Daniel Baecker, Ronald Gust","doi":"10.1016/j.ejmech.2025.117919","DOIUrl":null,"url":null,"abstract":"SS-, <em>RR</em>-, <em>SR</em>- and <em>RR</em>/<em>SS</em>-configured 1,3-diethyl-4,5-diphenyl-4,5-dihydro-1<em>H</em>-imidazol-2-ylidenes were introduced as new imidazoline-based <em>N</em>-heterocyclic carbene (NHC) ligands for the design of antitumor-active (NHC)gold(I) complexes (halido(NHC)gold(I) complexes: chlorido (<strong>5a</strong>-<strong>d</strong>), bromido (<strong>6a</strong>-<strong>d</strong>), iodido (<strong>7a</strong>-<strong>d</strong>); <em>SS</em>,<em>SS</em>-, <em>RR</em>,<em>RR</em>-, <em>SR</em>,<em>SR</em>-, and <em>RR</em>,<em>SS</em>-configured [(NHC)<sub>2</sub>Au(I)]<sup>+</sup> complexes: <strong>8a</strong>-<strong>d</strong>). X-ray structures of the <em>SS</em>-configured complexes <strong>5a-7a</strong> showed bis-equatorially arranged phenyl rings and disturbed columnar structures with increased Au-Au distances (&gt; 5.6 Å). The <em>SR</em>-configuration forced the phenyl ring in a synclinal position above the NHC plane allowing only the formation of separated dimers (<strong>5c-7c</strong>). In case of the [(NHC)<sub>2</sub>Au(I)]<sup>+</sup> complex <strong>8c</strong>, single molecules were observed in the crystals. The steric and dynamic conditions reduced ligand scrambling in solution and thus increased stability. The complexes showed higher growth-inhibitory effects in ovarian (A2780wt, A2780cis) than in breast cancer cells (MDA-MB-231, MCF-7) and circumvented the Cisplatin-resistance in A2780 cells (effects in A2780wt = A2780cis). Chlorido- and bromido(NHC)gold(I) complexes caused comparable effects, because of a fast Br/Cl exchange (<strong>6a-d</strong> → <strong>5a-d</strong>). The iodido(NHC)gold(I) complexes <strong>7a-d</strong> were more active, due to a partial degradation to <strong>8a-d</strong>. The latter were the most cytotoxic compounds of this study. The configuration of the NHC ligand did not influence the cytotoxicity of the complexes. Enantiomers and diastereomers showed the same antimetabolic effects. On the examples of <strong>5a-d</strong> and <strong>8a-d</strong>, the cellular uptake was studied. The maximum gold levels in A2780wt and MDA-MB-231 cells were achieved within 30 min of incubation. At concentrations corresponding to the IC<sub>50</sub> values of the antiproliferative effect (<strong>5a-d</strong>: 20 μM, <strong>8a-d</strong>: 5 μM), <strong>5b</strong>, <strong>5c</strong> and <strong>5d</strong> induced almost the same gold content in A2780wt cells, which was 30-50% lower than that of <strong>5a</strong>. The trend of accumulation for [(NHC)<sub>2</sub>Au(I)]<sup>+</sup> complexes was <strong>8d</strong> &lt; <strong>8a</strong> &lt; <strong>8b</strong> &lt; <strong>8c</strong>. Furthermore, <strong>5a-d</strong> inhibited the cyclooxygenase-1 (COX-1) and thioredoxin reductase (TrxR) and upregulated the glutathione (GSH) level in A2780wt cells. Contrarily, <strong>8a-d</strong> did not reduce COX-1 and TrxR activity, but led to moderate GSH down-regulation. The GSH level was not lowered in favour of GSSG, demonstrating that <strong>8a-d</strong> influence the formation of GSH.© 2017 Elsevier Inc. All rights reserved.","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"206 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2025.117919","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

SS-, RR-, SR- and RR/SS-configured 1,3-diethyl-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-ylidenes were introduced as new imidazoline-based N-heterocyclic carbene (NHC) ligands for the design of antitumor-active (NHC)gold(I) complexes (halido(NHC)gold(I) complexes: chlorido (5a-d), bromido (6a-d), iodido (7a-d); SS,SS-, RR,RR-, SR,SR-, and RR,SS-configured [(NHC)2Au(I)]+ complexes: 8a-d). X-ray structures of the SS-configured complexes 5a-7a showed bis-equatorially arranged phenyl rings and disturbed columnar structures with increased Au-Au distances (> 5.6 Å). The SR-configuration forced the phenyl ring in a synclinal position above the NHC plane allowing only the formation of separated dimers (5c-7c). In case of the [(NHC)2Au(I)]+ complex 8c, single molecules were observed in the crystals. The steric and dynamic conditions reduced ligand scrambling in solution and thus increased stability. The complexes showed higher growth-inhibitory effects in ovarian (A2780wt, A2780cis) than in breast cancer cells (MDA-MB-231, MCF-7) and circumvented the Cisplatin-resistance in A2780 cells (effects in A2780wt = A2780cis). Chlorido- and bromido(NHC)gold(I) complexes caused comparable effects, because of a fast Br/Cl exchange (6a-d5a-d). The iodido(NHC)gold(I) complexes 7a-d were more active, due to a partial degradation to 8a-d. The latter were the most cytotoxic compounds of this study. The configuration of the NHC ligand did not influence the cytotoxicity of the complexes. Enantiomers and diastereomers showed the same antimetabolic effects. On the examples of 5a-d and 8a-d, the cellular uptake was studied. The maximum gold levels in A2780wt and MDA-MB-231 cells were achieved within 30 min of incubation. At concentrations corresponding to the IC50 values of the antiproliferative effect (5a-d: 20 μM, 8a-d: 5 μM), 5b, 5c and 5d induced almost the same gold content in A2780wt cells, which was 30-50% lower than that of 5a. The trend of accumulation for [(NHC)2Au(I)]+ complexes was 8d < 8a < 8b < 8c. Furthermore, 5a-d inhibited the cyclooxygenase-1 (COX-1) and thioredoxin reductase (TrxR) and upregulated the glutathione (GSH) level in A2780wt cells. Contrarily, 8a-d did not reduce COX-1 and TrxR activity, but led to moderate GSH down-regulation. The GSH level was not lowered in favour of GSSG, demonstrating that 8a-d influence the formation of GSH.© 2017 Elsevier Inc. All rights reserved.

Abstract Image

引入1,3-二乙基-4,5-二苯基-4,5-二氢- 1h -咪唑-2-吡啶作为抗肿瘤活性(NHC)金(I)配合物的新配体:减少配体混乱和提高肿瘤细胞选择性的方法
介绍了SS-、RR-、SR-和RR/SS配置的1,3-二乙基-4,5-二苯基-4,5-二氢- 1h -咪唑-2-酰基作为新型咪唑基n -杂环羰基(NHC)配体,用于设计抗肿瘤金(NHC)配合物(卤代(NHC)金(I)配合物:氯代(5 -d)、溴代(6 -d)、碘代(7 -d);SS,SS-, RR,RR-, SR,SR-和RR,SS配置[(NHC)2Au(I)]+配合物:8a-d)。ss构型配合物5a-7a的x射线结构显示出双赤道排列的苯环和随着Au-Au距离的增加而扰动的柱状结构(>;5.6)。sr构型迫使苯环在NHC平面上方的向斜位置,只允许形成分离的二聚体(5c-7c)。对于[(NHC)2Au(I)]+配合物8c,在晶体中观察到单个分子。空间和动态条件减少了配体在溶液中的乱序,从而提高了稳定性。这些复合物在卵巢癌细胞(A2780wt, A2780cis)中的生长抑制作用高于乳腺癌细胞(MDA-MB-231, MCF-7),并绕过了A2780细胞的顺铂耐药(A2780wt = A2780cis)。氯-和溴(NHC)金(I)配合物由于Br/Cl的快速交换(6a-d→5a-d)而具有类似的效果。碘(NHC)金(I)配合物7a-d由于对8a-d的部分降解而更有活性。后者是本研究中最具细胞毒性的化合物。NHC配体的构型不影响配合物的细胞毒性。对映体和非对映体具有相同的抗代谢作用。以5a-d和8a-d为例,研究了细胞摄取。A2780wt和MDA-MB-231细胞的最高金水平在孵育30分钟内达到。在相应浓度下(5a-d: 20 μM, 8a-d: 5 μM), 5b、5c和5d诱导的A2780wt细胞含金量几乎相同,比5a低30-50%。[(NHC)2Au(I)]+络合物的积累趋势为8d <;8 & lt;8 b & lt;8 c。此外,5a-d抑制A2780wt细胞环氧化酶-1 (COX-1)和硫氧还蛋白还原酶(TrxR),上调谷胱甘肽(GSH)水平。相反,8a-d不降低COX-1和TrxR活性,但导致GSH适度下调。GSH水平没有降低,有利于GSSG,表明8a-d影响GSH的形成。©2017 Elsevier Inc.版权所有。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.70
自引率
9.00%
发文量
863
审稿时长
29 days
期刊介绍: The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers. A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信